| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | DCAF1 CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 PAK6 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC | 9.26e-06 | 363 | 163 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 MYH6 ABCC4 DDX12P DNAH10 MYO5A DYNC2H1 DHX38 MCM4 MSH5 DNAH1 ATP2C1 DQX1 HELZ2 DHX35 ATP1B3 ABCG5 | 1.17e-05 | 614 | 163 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | DCAF1 CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 PAK6 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC | 7.84e-05 | 446 | 163 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | acetyl-CoA C-myristoyltransferase activity | 1.98e-04 | 3 | 163 | 2 | GO:0050633 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.26e-04 | 15 | 163 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 TENT4B CDC42BPA DAPK2 RIPK2 DAPK1 OAS3 DAPK3 LCK PAK6 WNK1 MTOR FLAD1 CDIPT PAK1 PRKCH MAP3K15 PRKDC MVK | 2.41e-04 | 938 | 163 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | protein antigen binding | 2.77e-04 | 16 | 163 | 3 | GO:1990405 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCC4 DDX12P DNAH10 DYNC2H1 DHX38 MCM4 ATP2C1 DQX1 HELZ2 DHX35 ABCG5 | 2.79e-04 | 441 | 163 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | small GTPase binding | 3.16e-04 | 321 | 163 | 10 | GO:0031267 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 3.93e-04 | 4 | 163 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.98e-04 | 18 | 163 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein kinase activity | DCAF1 CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 LCK PAK6 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC | 4.18e-04 | 600 | 163 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | DCAF1 CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 LCK PAK6 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC MVK | 7.20e-04 | 709 | 163 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | GTPase binding | 7.70e-04 | 360 | 163 | 10 | GO:0051020 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 9.72e-04 | 6 | 163 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 1.35e-03 | 7 | 163 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 1.35e-03 | 7 | 163 | 2 | GO:0003988 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.51e-03 | 28 | 163 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | kinase activity | DCAF1 CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 LCK PAK6 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC MVK | 1.52e-03 | 764 | 163 | 15 | GO:0016301 |
| GeneOntologyCellularComponent | sperm end piece | 1.76e-04 | 3 | 161 | 2 | GO:0097229 | |
| GeneOntologyCellularComponent | RecQ family helicase-topoisomerase III complex | 3.50e-04 | 4 | 161 | 2 | GO:0031422 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.29e-04 | 238 | 161 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | platelet dense granule | 5.39e-04 | 21 | 161 | 3 | GO:0042827 | |
| GeneOntologyCellularComponent | DNA helicase complex | 5.81e-04 | 5 | 161 | 2 | GO:0033202 | |
| GeneOntologyCellularComponent | apical part of cell | ABCC4 SLC26A3 DSG2 DYNC2H1 SLCO2B1 USP9X SRR IQGAP1 AMOTL1 SLC22A5 SLC5A8 ATP1B3 ABCG5 | 6.89e-04 | 592 | 161 | 13 | GO:0045177 |
| Domain | DAPK1 | 6.77e-07 | 3 | 165 | 3 | IPR020676 | |
| Domain | P-loop_NTPase | ABCC3 MYH6 ABCC4 DNAH10 MYO5A DYNC2H1 DHX38 DAPK1 MCM4 MSH5 ARHGAP35 IQGAP1 DNAH1 NLRP14 DQX1 HELZ2 MFN2 DHX35 CHST2 HYDIN ABCG5 | 1.93e-05 | 848 | 165 | 21 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 2.29e-04 | 14 | 165 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.29e-04 | 14 | 165 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.29e-04 | 14 | 165 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.29e-04 | 14 | 165 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.29e-04 | 14 | 165 | 3 | IPR011704 | |
| Domain | MT | 2.29e-04 | 14 | 165 | 3 | PF12777 | |
| Domain | AAA_8 | 2.29e-04 | 14 | 165 | 3 | PF12780 | |
| Domain | AAA_5 | 2.29e-04 | 14 | 165 | 3 | PF07728 | |
| Domain | DHC_fam | 2.85e-04 | 15 | 165 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.85e-04 | 15 | 165 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.85e-04 | 15 | 165 | 3 | IPR004273 | |
| Domain | AAA | 2.95e-04 | 144 | 165 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 2.95e-04 | 144 | 165 | 7 | IPR003593 | |
| Domain | Kinase-like_dom | CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 LCK PAK6 ARHGAP35 WNK1 MTOR PAK1 PRKCH MAP3K15 PRKDC | 3.33e-04 | 542 | 165 | 14 | IPR011009 |
| Domain | - | ABCC3 ABCC4 DNAH10 DYNC2H1 DHX38 MCM4 MSH5 ARHGAP35 DNAH1 NLRP14 DQX1 HELZ2 MFN2 DHX35 CHST2 HYDIN ABCG5 | 3.34e-04 | 746 | 165 | 17 | 3.40.50.300 |
| Domain | PBD | 3.48e-04 | 16 | 165 | 3 | SM00285 | |
| Domain | DUF1605 | 4.20e-04 | 17 | 165 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 4.20e-04 | 17 | 165 | 3 | PF07717 | |
| Domain | HA2 | 5.01e-04 | 18 | 165 | 3 | SM00847 | |
| Domain | HA2 | 5.01e-04 | 18 | 165 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 5.01e-04 | 18 | 165 | 3 | IPR007502 | |
| Domain | CRIB | 6.91e-04 | 20 | 165 | 3 | PS50108 | |
| Domain | Thiolase_AS | 7.62e-04 | 5 | 165 | 2 | IPR020610 | |
| Domain | Thiolase_acyl_enz_int_AS | 7.62e-04 | 5 | 165 | 2 | IPR020615 | |
| Domain | FATC | 7.62e-04 | 5 | 165 | 2 | PF02260 | |
| Domain | CRIB_dom | 8.01e-04 | 21 | 165 | 3 | IPR000095 | |
| Domain | Thiolase_C | 1.14e-03 | 6 | 165 | 2 | PF02803 | |
| Domain | THIOLASE_2 | 1.14e-03 | 6 | 165 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 1.14e-03 | 6 | 165 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 1.14e-03 | 6 | 165 | 2 | PS00099 | |
| Domain | Thiolase_N | 1.14e-03 | 6 | 165 | 2 | IPR020616 | |
| Domain | Thiolase_C | 1.14e-03 | 6 | 165 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 1.14e-03 | 6 | 165 | 2 | IPR020613 | |
| Domain | Thiolase | 1.14e-03 | 6 | 165 | 2 | IPR002155 | |
| Domain | Thiolase_N | 1.14e-03 | 6 | 165 | 2 | PF00108 | |
| Domain | FAT | 1.14e-03 | 6 | 165 | 2 | PS51189 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | PS51190 | |
| Domain | FAT | 1.14e-03 | 6 | 165 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.14e-03 | 6 | 165 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.14e-03 | 6 | 165 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.14e-03 | 6 | 165 | 2 | IPR014009 | |
| Domain | FATC | 1.14e-03 | 6 | 165 | 2 | SM01343 | |
| Domain | Ser/Thr_kinase_AS | CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 PAK6 WNK1 PAK1 PRKCH MAP3K15 | 1.31e-03 | 357 | 165 | 10 | IPR008271 |
| Domain | S_TKc | CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 PAK6 WNK1 PAK1 PRKCH MAP3K15 | 1.36e-03 | 359 | 165 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDC42BPA DAPK2 RIPK2 DAPK1 DAPK3 PAK6 WNK1 PAK1 PRKCH MAP3K15 | 1.45e-03 | 362 | 165 | 10 | PS00108 |
| Domain | WASP_C | 1.58e-03 | 7 | 165 | 2 | IPR011026 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ABCC3 SP1 MBTPS1 PSAP ACAA1 ARSK CYP27A1 PLA2G4E NDUFAB1 CREBBP NCOR2 SEC24D PNPLA6 FDPS CDIPT SLC22A5 HELZ2 PLEKHA5 HADHB MED23 ALDH3A2 ALOX15 MVK | 4.41e-07 | 757 | 131 | 23 | M27451 |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 7.13e-07 | 55 | 131 | 7 | M27001 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | ABCC3 MBTPS1 PSAP ACAA1 ARSK CYP27A1 PLA2G4E NDUFAB1 NCOR2 PNPLA6 FDPS CDIPT SLC22A5 HELZ2 PLEKHA5 HADHB ALDH3A2 ALOX15 MVK | 4.43e-06 | 620 | 131 | 19 | MM15193 |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.33e-05 | 154 | 131 | 9 | M27832 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 4.14e-05 | 42 | 131 | 5 | M27172 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND | 8.97e-05 | 10 | 131 | 3 | M866 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP MCMBP TENT4B CHERP NCKAP1 DNAH10 DSG2 DYNC2H1 PDHB USP9X DHX38 MCM4 OAT PRPF8 SF1 WDR43 IQGAP1 PPP2R1A NF1 GCLC MTOR PRMT5 GLUD1 ALYREF PRKDC HADHB UBE3C TDRD6 CHST2 MED23 ALDH3A2 ATP1B3 TALDO1 RAD23B | 6.65e-15 | 1425 | 166 | 34 | 30948266 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AMPD1 MCMBP PSAP NCKAP1 DSG2 SPR PDHB USP9X ACO1 OAS3 PRPF8 WNK1 SF1 LGALS3BP IQGAP1 NCOR2 PPP2R1A MTOR GLUD1 PAK1 ALYREF PRKDC ATP1B3 TALDO1 UTRN MVK RAD23B | 3.93e-10 | 1367 | 166 | 27 | 32687490 |
| Pubmed | CHERP NCKAP1 MYO5A USP9X DHX38 MCM4 OAT PRPF8 WDR43 TASOR2 IQGAP1 PPP2R1A NF1 MTOR PRMT5 HELZ2 ALYREF PRKDC UTRN | 4.01e-10 | 653 | 166 | 19 | 22586326 | |
| Pubmed | HIF1A MCMBP CDC42BPA ACAA1 PDHB MCM4 OAT PRPF8 TRIP4 SF1 IQGAP1 DNAH1 NCOR2 PPP2R1A FDPS PRMT5 HGS GLUD1 PAK1 ALYREF DHX35 PRKDC HADHB TALDO1 RAD23B | 1.40e-09 | 1247 | 166 | 25 | 27684187 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KIFBP MCMBP PSAP NCKAP1 PDHB COG7 USP9X ACO1 DHX38 MCM4 WNK1 SF1 IQGAP1 PPP2R1A SEC24D SH3GLB1 GCLC MTOR FDPS PRMT5 HGS PRKDC UBE3C TALDO1 MVK RAD23B | 6.86e-09 | 1455 | 166 | 26 | 22863883 |
| Pubmed | 6.87e-09 | 120 | 166 | 9 | 27320910 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 CRYBG2 HIVEP2 CDC42BPA PIEZO1 EXTL3 ARHGAP35 WNK1 NCOR2 ZNF263 CELSR1 PNPLA6 MTOR KLHL21 SGSM2 HELZ2 MFN2 PRKDC UBE3C SLC45A1 ALKBH6 TOP3A | 1.69e-08 | 1105 | 166 | 22 | 35748872 |
| Pubmed | ABCC3 ABCC4 SLCO2B1 CYP27A1 NDUFAB1 PNPLA6 SLC22A5 CHST2 ALDH3A2 ABCG5 | 3.44e-08 | 193 | 166 | 10 | 19343046 | |
| Pubmed | KIFBP NCKAP1 USP9X WNK1 PPP2R1A NF1 AMOTL1 HGS PLEKHA5 PRKDC HADHB TRAPPC14 ALDH3A2 UTRN | 3.56e-08 | 446 | 166 | 14 | 24255178 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TENT4B MYO5A DSG2 DHX38 OAS3 DAPK3 OAT PRPF8 SF1 LGALS3BP WDR43 TASOR2 IQGAP1 PPP2R1A PNPLA6 PRMT5 AMOTL1 GLUD1 HELZ2 PLEKHA5 ALYREF PRKDC HADHB | 3.65e-08 | 1257 | 166 | 23 | 36526897 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 CHERP DSG2 COG7 DHX38 LCK PRPF8 LGALS3BP WDR43 TASOR2 IQGAP1 RMI1 PPP2R1A TIPIN PRMT5 ALYREF DHX35 PRKDC HADHB ALDH3A2 TOP3A RAD23B | 3.70e-08 | 1155 | 166 | 22 | 20360068 |
| Pubmed | SP1 HIVEP2 CDC42BPA EXTL3 PAK6 WNK1 CREBBP EGR1 HGS PAK1 PLEKHA5 PRKCH PRKDC WASH2P | 1.02e-07 | 486 | 166 | 14 | 20936779 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 9747039 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 31752873 | ||
| Pubmed | The death-associated protein kinases: structure, function, and beyond. | 1.07e-07 | 3 | 166 | 3 | 16756490 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MCMBP HIVEP2 CDC42BPA NCKAP1 DSG2 DAPK2 RIPK2 DAPK3 LCK PAK6 WNK1 FSIP2 NF1 MTOR PRMT5 PLEKHA5 TRAPPC14 UTRN | 1.83e-07 | 861 | 166 | 18 | 36931259 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 MCMBP DSG2 PDHB MCM4 OAT PRPF8 PPP2R1A ATP2C1 MTOR FLAD1 CDIPT GLUD1 ALYREF PRKDC UBE3C ALDH3A2 UTRN RAD23B | 2.36e-07 | 974 | 166 | 19 | 28675297 |
| Pubmed | NCKAP1 MYO5A PDHB MCM4 OAT PRPF8 SF1 LGALS3BP IQGAP1 NF1 CDIPT HELZ2 ALYREF PRKDC HADHB ALDH3A2 TALDO1 | 3.44e-07 | 803 | 166 | 17 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACAA1 DYNC2H1 ACO1 DAPK1 PRPF8 IQGAP1 DNAH1 PPP2R1A PRMT5 BRPF1 ALYREF ZFHX3 PRKDC HADHB TALDO1 UTRN HYDIN | 3.68e-07 | 807 | 166 | 17 | 30575818 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH6 CDC42BPA NCKAP1 SPR HAGHL PDHB RIPK2 DAPK3 OAT LCK SLC25A25 CREBBP NCOR2 PPP2R1A NF1 SH3GLB1 UTRN RAD23B | 4.09e-07 | 910 | 166 | 18 | 36736316 |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 21343542 | ||
| Pubmed | CHERP NCKAP1 DSG2 PDHB COG7 USP9X MCM4 PRPF8 IQGAP1 PPP2R1A MTOR PRKDC HADHB UBE3C ALDH3A2 | 4.75e-07 | 638 | 166 | 15 | 33239621 | |
| Pubmed | 4.92e-07 | 197 | 166 | 9 | 31620119 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | USP9X MCM4 OAT PRPF8 LGALS3BP NCOR2 PPP2R1A PRMT5 GLUD1 PRKDC | 5.11e-07 | 258 | 166 | 10 | 21081666 |
| Pubmed | PDHB USP9X OAT PRPF8 WDR43 IQGAP1 PPP2R1A SEC24D ISOC2 PRMT5 CDIPT HGS ATP1B3 | 6.54e-07 | 484 | 166 | 13 | 31995728 | |
| Pubmed | PSAP ACAA1 SPR PDHB PYURF OAT NDUFAB1 IQGAP1 PPP2R1A ISOC2 FDPS HGS GLUD1 MIPEP HADHB ATP1B3 UTRN | 8.69e-07 | 859 | 166 | 17 | 31536960 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | USP9X DHX38 OAS3 MCM4 PRPF8 WNK1 IQGAP1 GCLC GLUD1 HELZ2 PRKDC | 9.11e-07 | 344 | 166 | 11 | 30333137 |
| Pubmed | HIVEP2 PSAP MYO5A PDHB USP9X ACO1 OAT EXTL3 PRPF8 CREBBP SF1 IQGAP1 SGSM2 GLUD1 PAK1 DHX35 PRKDC ALKBH6 UTRN USP33 RAD23B | 9.46e-07 | 1285 | 166 | 21 | 35914814 | |
| Pubmed | KIFBP ABCC4 MCMBP DSG2 PDHB USP9X OAT SRR PRPF8 IQGAP1 PPP2R1A PRMT5 FLAD1 CDIPT HGS PRKDC HADHB | 1.17e-06 | 878 | 166 | 17 | 37223481 | |
| Pubmed | DCAF1 KIFBP MCMBP PDHB USP9X MCM4 PRPF8 TRIP4 IQGAP1 PPP2R1A ISOC2 TIPIN PRMT5 FLAD1 ALYREF PRKDC HADHB ALDH3A2 ATP1B3 PRG4 RAD23B | 1.73e-06 | 1335 | 166 | 21 | 29229926 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 NCKAP1 MYO5A SPR PDHB DHX38 OAS3 MCM4 PRPF8 CREBBP IQGAP1 NCOR2 PPP2R1A NF1 PNPLA6 FDPS PLEKHA5 ALYREF PRKDC HADHB UTRN | 2.13e-06 | 1353 | 166 | 21 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHERP MYO5A DSG2 USP9X MCM4 PRPF8 SF1 LGALS3BP WDR43 IQGAP1 PPP2R1A NF1 PRMT5 GLUD1 ALYREF PRKDC HADHB UTRN | 2.19e-06 | 1024 | 166 | 18 | 24711643 |
| Pubmed | AMPD1 PDHB MCM4 OAT SRR PRPF8 LGALS3BP IQGAP1 PRMT5 CDIPT GLUD1 ALYREF PRKDC ALDH3A2 ATP1B3 | 2.31e-06 | 725 | 166 | 15 | 27025967 | |
| Pubmed | DCAF1 MYO5A DSG2 USP9X ACO1 ATP2C1 PNPLA6 HGS HADHB UBE3C ALDH3A2 TALDO1 MVK RAD23B | 2.41e-06 | 634 | 166 | 14 | 34591612 | |
| Pubmed | DCAF1 KIFBP MCMBP CDC42BPA MYO5A DSG2 DYNC2H1 PDHB PIEZO1 OAT PRPF8 TRIP4 LGALS3BP PNPLA6 HGS GLUD1 PLEKHA5 TYW1 HADHB ALDH3A2 ATP1B3 USP33 | 2.60e-06 | 1487 | 166 | 22 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | KIFBP PDHB DAPK3 OAT NDUFAB1 SLC25A25 SF1 LGALS3BP WDR43 FLAD1 CDIPT GLUD1 MIPEP MFN2 ALYREF PRKCH DHX35 HADHB UBE3C ALDH3A2 TOP3A USP33 | 2.87e-06 | 1496 | 166 | 22 | 32877691 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.91e-06 | 313 | 166 | 10 | 38270169 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | ACAA1 SPR PDHB ACO1 CYP27A1 PYURF OAT NDUFAB1 SLC25A25 FSIP2 ISOC2 SUOX FDPS GLUD1 MIPEP MFN2 HADHB ALDH3A2 | 2.98e-06 | 1047 | 166 | 18 | 18614015 |
| Pubmed | 3.30e-06 | 248 | 166 | 9 | 32963011 | ||
| Pubmed | 3.52e-06 | 250 | 166 | 9 | 18660489 | ||
| Pubmed | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. | 3.69e-06 | 7 | 166 | 3 | 24278015 | |
| Pubmed | KIFBP NCKAP1 MYO5A USP9X RIPK2 DAPK1 DAPK3 IQGAP1 NCOR2 PPP2R1A ZNF263 NF1 MTOR PAK1 MFN2 PLEKHA5 ALYREF | 4.03e-06 | 963 | 166 | 17 | 28671696 | |
| Pubmed | 4.52e-06 | 89 | 166 | 6 | 23891004 | ||
| Pubmed | MYH6 NCKAP1 MYO5A PDHB USP9X DAPK1 DAPK3 OAT ARHGAP35 IQGAP1 AGBL4 PPP2R1A NF1 PNPLA6 FGD4 PRMT5 CDIPT GLUD1 PLEKHA5 HADHB UTRN | 5.08e-06 | 1431 | 166 | 21 | 37142655 | |
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 9535855 | ||
| Pubmed | Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. | 9.37e-06 | 28 | 166 | 4 | 19596686 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MCMBP DDX12P PDHB USP9X MCM4 OAT PRPF8 LGALS3BP PPP2R1A KLHL21 PRMT5 CDIPT GLUD1 MFN2 PRKDC HADHB UBE3C ALDH3A2 RAD23B | 9.82e-06 | 1257 | 166 | 19 | 37317656 |
| Pubmed | TENT4B CDC42BPA NCKAP1 MYO5A DSG2 PIEZO1 DHX38 TRIP4 WDR43 IQGAP1 CELSR1 PNPLA6 FGD4 PRMT5 HELZ2 ZFHX3 MED23 ALDH3A2 UTRN FHIP1A RAD23B | 1.01e-05 | 1497 | 166 | 21 | 31527615 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | ACAA1 SPR PDHB ACO1 CYP27A1 OAT NDUFAB1 SLC25A25 FSIP2 SUOX FDPS GLUD1 MIPEP MFN2 HADHB ALDH3A2 | 1.02e-05 | 926 | 166 | 16 | 20877624 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PSAP NCKAP1 MYO5A PDHB USP9X MCM4 PRPF8 SF1 IQGAP1 PPP2R1A SH3GLB1 PRMT5 AMOTL1 GLUD1 ALYREF PRKDC TALDO1 RAD23B | 1.06e-05 | 1149 | 166 | 18 | 35446349 |
| Pubmed | TopBP1 controls BLM protein level to maintain genome stability. | 1.08e-05 | 29 | 166 | 4 | 24239288 | |
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 20347598 | ||
| Pubmed | ABCC4 CHERP ACAA1 MYO5A USP9X DHX38 MCM4 PRPF8 NCOR2 ATP2C1 NF1 PNPLA6 MTOR CDIPT HELZ2 PLEKHA5 PRKDC PSD4 | 1.32e-05 | 1168 | 166 | 18 | 19946888 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.40e-05 | 226 | 166 | 8 | 37839992 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DYNC2H1 COG7 USP9X ACO1 OAT EXTL3 NF1 GCLC SLC22A5 MIPEP WDR83OS SGCE TYW1 PRKDC UBE3C SLC45A1 RAD23B | 1.42e-05 | 1061 | 166 | 17 | 33845483 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 1.64e-05 | 231 | 166 | 8 | 36597993 | |
| Pubmed | PDHB USP9X PRPF8 PPP2R1A NF1 MTOR PRMT5 CDIPT PRKDC HADHB ALDH3A2 ATP1B3 RAD23B | 1.79e-05 | 657 | 166 | 13 | 36180527 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 1.79e-05 | 113 | 166 | 6 | 23403292 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 MBTPS1 ABCC4 PSAP DSG2 ARSK PIEZO1 EXTL3 LGALS3BP CELSR1 NF1 PRMT5 CDIPT PLEKHA5 SGCE TYW1 ALDH3A2 ATP1B3 | 1.91e-05 | 1201 | 166 | 18 | 35696571 |
| Pubmed | KIFBP COG7 OAS3 OAT EXTL3 PRPF8 SF1 LGALS3BP IQGAP1 PPP2R1A MTOR FDPS PRMT5 ALYREF PRKDC HADHB UBE3C TRAPPC14 ALDH3A2 ATP1B3 | 1.92e-05 | 1440 | 166 | 20 | 30833792 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CHERP PSAP ARSK PDHB USP9X OAS3 MCM4 OAT PRPF8 NDUFAB1 LGALS3BP IQGAP1 NCOR2 SEC24D CDIPT GLUD1 HADHB ALDH3A2 PRG4 ALOX15 | 2.14e-05 | 1451 | 166 | 20 | 30550785 |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23437231 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25181405 | ||
| Pubmed | Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2. | 2.26e-05 | 2 | 166 | 2 | 18535204 | |
| Pubmed | TDRD6 mediates early steps of spliceosome maturation in primary spermatocytes. | 2.26e-05 | 2 | 166 | 2 | 28263986 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9284934 | ||
| Pubmed | A PAK6-IQGAP1 complex promotes disassembly of cell-cell adhesions. | 2.26e-05 | 2 | 166 | 2 | 24352566 | |
| Pubmed | HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells. | 2.26e-05 | 2 | 166 | 2 | 25349289 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12242281 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28887525 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28065856 | ||
| Pubmed | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway. | 2.26e-05 | 2 | 166 | 2 | 27930338 | |
| Pubmed | Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. | 2.26e-05 | 2 | 166 | 2 | 25242307 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 15910736 | ||
| Pubmed | Effect of hypoxia on the expression of iron regulatory proteins 1 and the mechanisms involved. | 2.26e-05 | 2 | 166 | 2 | 21360641 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22266372 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26063890 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31135072 | ||
| Pubmed | Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. | 2.26e-05 | 2 | 166 | 2 | 33431674 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 30941147 | ||
| Pubmed | Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. | 2.26e-05 | 2 | 166 | 2 | 16341243 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 38216092 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 37092319 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21748792 | ||
| Pubmed | Hypoxia: Turning vessels into vassals of cancer immunotolerance. | 2.26e-05 | 2 | 166 | 2 | 32470491 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 11997063 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25720411 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26826164 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23872956 | ||
| Pubmed | Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. | 2.26e-05 | 2 | 166 | 2 | 22851646 | |
| Pubmed | Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. | 2.26e-05 | 2 | 166 | 2 | 27235137 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31116076 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 24509834 | ||
| Pubmed | Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response. | 2.26e-05 | 2 | 166 | 2 | 11959977 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16579968 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 36385451 | ||
| Pubmed | Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. | 2.26e-05 | 2 | 166 | 2 | 22160140 | |
| Pubmed | Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. | 2.26e-05 | 2 | 166 | 2 | 9525578 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 33773069 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22499342 | ||
| Interaction | BIRC3 interactions | MBTPS1 CHERP NCKAP1 DNAH10 DSG2 DYNC2H1 PDHB USP9X DHX38 RIPK2 MCM4 OAT PRPF8 SF1 WDR43 IQGAP1 NCOR2 PPP2R1A NF1 MTOR PRMT5 GLUD1 ALYREF PRKDC HADHB UBE3C TDRD6 CHST2 ALDH3A2 ATP1B3 TALDO1 RAD23B | 2.44e-08 | 1334 | 163 | 32 | int:BIRC3 |
| Interaction | BCL6 interactions | SP1 PSAP MCM4 ARHGAP35 CREBBP NCOR2 PRMT5 HELZ2 PAK1 MED23 TALDO1 RAD23B | 3.73e-07 | 229 | 163 | 12 | int:BCL6 |
| Interaction | HIF1A interactions | SP1 MYH6 HIF1A USP9X PRPF8 CREBBP IQGAP1 PPP2R1A PNPLA6 MTOR GLUD1 PLEKHA5 PRKDC UBE3C MED23 RAD23B | 6.18e-07 | 441 | 163 | 16 | int:HIF1A |
| Interaction | SIRT7 interactions | DCAF1 CHERP NCKAP1 MYO5A USP9X DHX38 MCM4 OAT PRPF8 WDR43 TASOR2 IQGAP1 PPP2R1A NF1 MTOR PRMT5 HELZ2 ALYREF PRKDC UTRN | 2.57e-06 | 744 | 163 | 20 | int:SIRT7 |
| Interaction | RELA interactions | DCAF1 SP1 HIF1A CREBBP TRIP4 NCOR2 SUOX EGR1 PRMT5 BRPF1 PAK1 ZFHX3 PRKDC MED23 ALDH3A2 | 9.77e-06 | 485 | 163 | 15 | int:RELA |
| Interaction | RORA interactions | 1.50e-05 | 39 | 163 | 5 | int:RORA | |
| Interaction | ANKRD55 interactions | 1.72e-05 | 228 | 163 | 10 | int:ANKRD55 | |
| Interaction | LGALS9 interactions | ABCC4 PDHB USP9X PIEZO1 OAT PRPF8 LGALS3BP WDR43 IQGAP1 PPP2R1A SEC24D ISOC2 PRMT5 CDIPT HGS ATP1B3 | 2.38e-05 | 588 | 163 | 16 | int:LGALS9 |
| Interaction | ING5 interactions | 3.97e-05 | 114 | 163 | 7 | int:ING5 | |
| Interaction | AKT1 interactions | SP1 HIF1A PDHB SRR WNK1 CREBBP IQGAP1 NCOR2 PPP2R1A NF1 MTOR PAK1 ALYREF PRKDC KLRC1 USP33 | 4.24e-05 | 617 | 163 | 16 | int:AKT1 |
| Interaction | CD274 interactions | DCAF1 COG7 USP9X MCM4 OAT NF1 MTOR GLUD1 ALYREF PRKDC UBE3C RAD23B | 4.84e-05 | 369 | 163 | 12 | int:CD274 |
| Interaction | HDAC5 interactions | HIF1A USP9X MCM4 OAT PRPF8 SF1 ITIH3 LGALS3BP NCOR2 PPP2R1A PRMT5 GLUD1 PRKDC | 5.18e-05 | 432 | 163 | 13 | int:HDAC5 |
| Interaction | TNFSF13B interactions | 5.22e-05 | 119 | 163 | 7 | int:TNFSF13B | |
| Interaction | NTRK3 interactions | DSG2 LGALS3BP MTOR CDIPT HGS GLUD1 PLEKHA5 PRKDC HADHB UBE3C ALDH3A2 ATP1B3 | 5.50e-05 | 374 | 163 | 12 | int:NTRK3 |
| Interaction | RPS6KL1 interactions | 5.66e-05 | 51 | 163 | 5 | int:RPS6KL1 | |
| Interaction | RHOJ interactions | CDC42BPA DSG2 PDHB USP9X PAK6 ARHGAP35 IQGAP1 ATP2C1 NF1 MTOR HGS PAK1 PLEKHA5 SGCE ATP1B3 UTRN | 5.74e-05 | 633 | 163 | 16 | int:RHOJ |
| Interaction | BRCA1 interactions | SP1 HIF1A PSAP USP9X ACO1 DHX38 MCM4 LCK CREBBP LGALS3BP IQGAP1 RMI1 CABYR NF1 EGR1 MTOR PRMT5 ALYREF PRKDC UBE3C ATP1B3 TALDO1 TOP3A RAD23B | 6.84e-05 | 1249 | 163 | 24 | int:BRCA1 |
| Interaction | EPAS1 interactions | 8.42e-05 | 173 | 163 | 8 | int:EPAS1 | |
| Interaction | C1D interactions | 8.91e-05 | 56 | 163 | 5 | int:C1D | |
| Interaction | ADRB2 interactions | DSG2 PDHB ARRDC4 OAT WNK1 NCOR2 HGS PRKDC HADHB ATP1B3 USP33 | 1.02e-04 | 339 | 163 | 11 | int:ADRB2 |
| Interaction | STK38 interactions | 1.20e-04 | 182 | 163 | 8 | int:STK38 | |
| Interaction | LATS2 interactions | DCAF1 HIF1A USP9X PPP2R1A PRMT5 AMOTL1 PLEKHA5 PRKDC UBE3C UTRN | 1.26e-04 | 289 | 163 | 10 | int:LATS2 |
| Interaction | TOP3B interactions | ABCC3 CRYBG2 HIVEP2 CDC42BPA PIEZO1 EXTL3 ARHGAP35 WNK1 IQGAP1 RMI1 NCOR2 ZNF263 CELSR1 PNPLA6 MTOR KLHL21 SGSM2 PRMT5 HELZ2 MFN2 PRKDC HADHB UBE3C SLC45A1 ALKBH6 TOP3A | 1.29e-04 | 1470 | 163 | 26 | int:TOP3B |
| Interaction | SRF interactions | 1.39e-04 | 139 | 163 | 7 | int:SRF | |
| Interaction | RHOV interactions | 1.66e-04 | 243 | 163 | 9 | int:RHOV | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 2.11e-06 | 5 | 109 | 3 | 1021 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN | DCAF1 MBTPS1 HIVEP2 USP9X ARHGAP35 SF1 SUOX SLC22A5 PAK1 USP33 | 5.98e-07 | 200 | 165 | 10 | M7080 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.94e-05 | 180 | 165 | 8 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.26e-05 | 240 | 165 | 9 | M39236 | |
| Coexpression | KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP | HIVEP2 PSAP NCKAP1 PDHB OAT PAK6 PRPF8 NDUFAB1 PPP2R1A PNPLA6 KLHL21 FDPS CDIPT HADHB TALDO1 RAD23B | 2.43e-05 | 755 | 165 | 16 | M2105 |
| Coexpression | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN | 2.74e-05 | 56 | 165 | 5 | M19492 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 3.84e-05 | 198 | 165 | 8 | M6511 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP | 3.98e-05 | 199 | 165 | 8 | M9424 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN | 3.98e-05 | 199 | 165 | 8 | M5579 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN | 4.12e-05 | 200 | 165 | 8 | M8297 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 4.12e-05 | 200 | 165 | 8 | M9909 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.12e-05 | 200 | 165 | 8 | M7444 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 4.12e-05 | 200 | 165 | 8 | M5185 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN | 4.12e-05 | 200 | 165 | 8 | M9040 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | 4.12e-05 | 200 | 165 | 8 | M9083 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | MBTPS1 KIFBP HIVEP2 PSAP NCKAP1 PDHB OAT PRPF8 NDUFAB1 PPP2R1A PAK1 UBE3C RAD23B | 4.58e-05 | 547 | 165 | 13 | M2110 |
| Coexpression | GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN | 8.38e-05 | 164 | 165 | 7 | M6919 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 9.04e-05 | 166 | 165 | 7 | M344 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | ABCC4 CDC42BPA MYO5A ARRDC4 USP9X MIER3 NDUFAB1 WNK1 WDR43 SEC24D ISOC2 CELSR1 SH3GLB1 EGR1 MIPEP PLEKHA5 UTRN | 9.87e-05 | 942 | 165 | 17 | M8144 |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | KIFBP HIVEP2 PSAP PDHB PRPF8 NDUFAB1 PPP2R1A PNPLA6 KLHL21 FDPS CDIPT GLUD1 TALDO1 RAD23B | 1.08e-04 | 680 | 165 | 14 | M2107 |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.35e-04 | 177 | 165 | 7 | M7632 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 1.36e-04 | 78 | 165 | 5 | M9911 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP | 1.77e-04 | 185 | 165 | 7 | M377 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ABCC4 CHERP CDC42BPA PDHB USP9X ACO1 DAPK1 OAT NDUFAB1 PPP2R1A ATP2C1 SUOX GCLC FDPS PRMT5 GLUD1 MIPEP PRKDC HADHB CHST2 RAD23B | 1.97e-04 | 1399 | 165 | 21 | M535 |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 2.09e-04 | 190 | 165 | 7 | M8457 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN | 2.27e-04 | 136 | 165 | 6 | M41157 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN | 2.77e-04 | 199 | 165 | 7 | M8709 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 2.77e-04 | 199 | 165 | 7 | M6646 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN | 2.77e-04 | 199 | 165 | 7 | M5382 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN | 2.77e-04 | 199 | 165 | 7 | M6481 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 2.77e-04 | 199 | 165 | 7 | M5263 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 2.77e-04 | 199 | 165 | 7 | M3151 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 2.77e-04 | 199 | 165 | 7 | M3156 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP | 2.85e-04 | 200 | 165 | 7 | M9455 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 2.85e-04 | 200 | 165 | 7 | M3399 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 2.85e-04 | 200 | 165 | 7 | M9382 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.85e-04 | 200 | 165 | 7 | M7020 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 2.85e-04 | 200 | 165 | 7 | M3407 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.85e-04 | 200 | 165 | 7 | M6090 | |
| Coexpression | HALLMARK_OXIDATIVE_PHOSPHORYLATION | 2.85e-04 | 200 | 165 | 7 | M5936 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 2.85e-04 | 200 | 165 | 7 | M5227 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 2.85e-04 | 200 | 165 | 7 | M5216 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN | 2.85e-04 | 200 | 165 | 7 | M6583 | |
| Coexpression | GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN | 2.85e-04 | 200 | 165 | 7 | M4118 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.85e-04 | 200 | 165 | 7 | M9190 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-08 | 197 | 166 | 9 | e73ca8c8f42cbcc56eaa5fe3d69abd1ce7b7bbca | |
| ToppCell | facs-Brain_Myeloid-Cortex_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-08 | 197 | 166 | 9 | 81379fe6bd14a1ba26f4a159497262adcb600b18 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-08 | 197 | 166 | 9 | 271c75f491d03bd248c7ec037ef02e39456f3ac0 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-08 | 197 | 166 | 9 | 9db329c6fea532dd1afb624f4c29c92407f45568 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-07 | 171 | 166 | 8 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.67e-07 | 184 | 166 | 8 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 6.19e-07 | 191 | 166 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.97e-07 | 194 | 166 | 8 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | MS-mono1|MS / Condition, Cell_class and T cell subcluster | 7.82e-07 | 197 | 166 | 8 | 32be48ee2a1397ed8f1ee8e60067dd9a96bece39 | |
| ToppCell | MS-mono1-|MS / Condition, Cell_class and T cell subcluster | 7.82e-07 | 197 | 166 | 8 | 4b038a193ecc1df65bcb608091c513ddafd6c818 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 197 | 166 | 8 | 173c0c8de4e69882a9f91189deeb4a651fefe551 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 8.12e-07 | 198 | 166 | 8 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-07 | 199 | 166 | 8 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-06 | 157 | 166 | 7 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-06 | 175 | 166 | 7 | a8b05972e1bec4de73feaa6c4a9bcbe6b50c8044 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.47e-06 | 176 | 166 | 7 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 177 | 166 | 7 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | CF-Myeloid-Alveolar_Macrophage|CF / Disease state, Lineage and Cell class | 5.18e-06 | 180 | 166 | 7 | 6a7c3a3f3a16ca9f109047adaf36f6a2746d6ab9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 185 | 166 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.20e-06 | 185 | 166 | 7 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-06 | 186 | 166 | 7 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | facs-Bladder|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 187 | 166 | 7 | dd5ca59417fd1b388fd975f0f3e1f3245d66ebc5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-06 | 189 | 166 | 7 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.38e-06 | 190 | 166 | 7 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.90e-06 | 192 | 166 | 7 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 192 | 166 | 7 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.90e-06 | 192 | 166 | 7 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 192 | 166 | 7 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 8.74e-06 | 195 | 166 | 7 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 8.74e-06 | 195 | 166 | 7 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 196 | 166 | 7 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-06 | 196 | 166 | 7 | eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 9.04e-06 | 196 | 166 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.04e-06 | 196 | 166 | 7 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 196 | 166 | 7 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.04e-06 | 196 | 166 | 7 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.04e-06 | 196 | 166 | 7 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 9.04e-06 | 196 | 166 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 196 | 166 | 7 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-06 | 197 | 166 | 7 | 179b56147cfb0a5f53c58615f2612b8ef68c8bb8 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.35e-06 | 197 | 166 | 7 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.42e-06 | 130 | 166 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | ASK440|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.66e-06 | 198 | 166 | 7 | f3ed6efd521c691debae32a803972bed5d069332 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 198 | 166 | 7 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 198 | 166 | 7 | 8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.66e-06 | 198 | 166 | 7 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.66e-06 | 198 | 166 | 7 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-06 | 198 | 166 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 199 | 166 | 7 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.98e-06 | 199 | 166 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 9.98e-06 | 199 | 166 | 7 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-06 | 199 | 166 | 7 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.98e-06 | 199 | 166 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.98e-06 | 199 | 166 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-06 | 199 | 166 | 7 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.21e-05 | 151 | 166 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.56e-05 | 155 | 166 | 6 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 156 | 166 | 6 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 162 | 166 | 6 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | droplet-Heart-4Chambers|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 162 | 166 | 6 | 5625ec6dae204d5537883f05ea546970628d10bb | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 162 | 166 | 6 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 162 | 166 | 6 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 168 | 166 | 6 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 168 | 166 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 168 | 166 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-05 | 169 | 166 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 172 | 166 | 6 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 173 | 166 | 6 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 173 | 166 | 6 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.88e-05 | 174 | 166 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.88e-05 | 174 | 166 | 6 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 175 | 166 | 6 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 175 | 166 | 6 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 175 | 166 | 6 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 176 | 166 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.20e-05 | 176 | 166 | 6 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 177 | 166 | 6 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 177 | 166 | 6 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 177 | 166 | 6 | 6561794ae3b14b5279b249eb5e93b80ef15ed82c | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 177 | 166 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 178 | 166 | 6 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.54e-05 | 178 | 166 | 6 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 5.71e-05 | 179 | 166 | 6 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.89e-05 | 180 | 166 | 6 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 182 | 166 | 6 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 182 | 166 | 6 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.26e-05 | 182 | 166 | 6 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 183 | 166 | 6 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 183 | 166 | 6 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 183 | 166 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 183 | 166 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-05 | 183 | 166 | 6 | 92d5a61b57851090eba558f19e2a7010043eff81 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 184 | 166 | 6 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 184 | 166 | 6 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 185 | 166 | 6 | 39f2b7a35253968f6d744c10ece1478a05cf24da | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.06e-05 | 186 | 166 | 6 | b9e0a819cd0b250f077b26eba99e6986d68d647b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 186 | 166 | 6 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.06e-05 | 186 | 166 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| Drug | ciprofibrate | ABCC3 PSAP SLCO2B1 CYP27A1 GCLC FDPS FLAD1 HELZ2 MED23 ABCG5 | 4.77e-07 | 170 | 165 | 10 | CID000002763 |
| Drug | Phlorhizin | ACAA1 SLCO2B1 USP9X ACO1 NDUFAB1 CREBBP GCLC PRKCH HADHB ALDH3A2 USP33 | 1.22e-06 | 235 | 165 | 11 | ctd:D010695 |
| Drug | soybean oil, phospholipid emulsion | 3.70e-06 | 5 | 165 | 3 | ctd:C545823 | |
| Drug | acetyl phosphate | 7.35e-06 | 98 | 165 | 7 | CID000000186 | |
| Drug | AC1L1A2K | 8.39e-06 | 66 | 165 | 6 | CID000000808 | |
| Drug | 4-amino-2,6-dinitrotoluene | ABCC3 ABCC4 TENT4B ACAA1 DAPK2 OAT MSH5 WNK1 SF1 NCOR2 PPP2R1A GCLC FDPS PRMT5 MFN2 | 9.88e-06 | 541 | 165 | 15 | ctd:C035207 |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.25e-05 | 194 | 165 | 9 | 4952_DN | |
| Drug | CTX-2 | 1.28e-05 | 7 | 165 | 3 | CID006441260 | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.31e-05 | 195 | 165 | 9 | 4145_DN | |
| Drug | Chenodeoxycholic Acid | 1.31e-05 | 107 | 165 | 7 | ctd:D002635 | |
| Drug | ruboxistaurin | 1.31e-05 | 107 | 165 | 7 | CID000153999 | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 3837_UP | |
| Drug | AC1L1TSE | 1.39e-05 | 72 | 165 | 6 | CID000060719 | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.42e-05 | 197 | 165 | 9 | 4604_DN | |
| Drug | MSD-1 | 1.45e-05 | 21 | 165 | 4 | CID009845018 | |
| Drug | valdecoxib | ABCC3 SLCO2B1 ACO1 OAT SLC25A25 ISOC2 SUOX EGR1 GCLC FDPS SLC22A5 GLUD1 PLEKHA5 ABCG5 MVK USP33 RAD23B | 1.53e-05 | 705 | 165 | 17 | ctd:C406224 |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 165 | 9 | 6249_DN | |
| Drug | CoA group | ACAA1 PDHB CYP27A1 SRR NDUFAB1 CREBBP GCLC FDPS SLC22A5 GLUD1 HADHB ALDH3A2 MVK | 1.73e-05 | 433 | 165 | 13 | CID000000317 |
| Drug | Methylcholanthrene | ABCC3 AMPD1 ABCC4 HIF1A SPR DAPK2 DHX38 DAPK1 MCM4 PAK6 ARHGAP35 ITIH3 ADORA3 ISOC2 FDPS TIPIN CD300LB HADHB CFAP61 TALDO1 PRG4 | 1.97e-05 | 1034 | 165 | 21 | ctd:D008748 |
| Drug | AC1Q68Z5 | ACAA1 PDHB ACO1 OAT NDUFAB1 CREBBP SH3GLB1 GLUD1 HADHB ALDH3A2 TALDO1 MVK | 2.62e-05 | 386 | 165 | 12 | CID000000181 |
| Drug | MKC-442 | 2.99e-05 | 25 | 165 | 4 | CID000065013 | |
| Drug | tert-butyl hydroperoxide | MBTPS1 KIFBP HIF1A MYO5A ACO1 RIPK2 OAS3 WDR43 NCOR2 PNPLA6 SH3GLB1 EGR1 GCLC PRKCH UBE3C CHST2 ALDH3A2 TOP3A ALOX15 | 3.09e-05 | 902 | 165 | 19 | CID000006410 |
| Drug | aspartic semialdehyde | 4.10e-05 | 27 | 165 | 4 | CID000000829 | |
| Drug | 2,6-dihydroxybenzoic acid | 4.27e-05 | 175 | 165 | 8 | CID000009338 | |
| Drug | oxalylglycine | 4.47e-05 | 54 | 165 | 5 | CID003080614 | |
| Drug | oltipraz | 5.33e-05 | 56 | 165 | 5 | ctd:C026209 | |
| Drug | phosphoramidate | 5.33e-05 | 56 | 165 | 5 | CID000065107 | |
| Drug | AC1L8WWP | 5.33e-05 | 56 | 165 | 5 | CID000388944 | |
| Drug | Amiodarone | ABCC3 MYH6 ABCC4 ACAA1 SPR SLCO2B1 ACO1 DAPK2 OAT ARHGAP35 SLC25A25 WNK1 ADORA3 EGR1 GCLC FGD4 MTOR FDPS BRPF1 SLC22A5 GLUD1 MIPEP MFN2 ALDH3A2 ABCG5 | 5.83e-05 | 1469 | 165 | 25 | ctd:D000638 |
| Drug | sulfate | ABCC3 ABCC4 HIF1A SLC26A3 PSAP MYO5A ARSK SPR PDHB SLCO2B1 OAT SRR EXTL3 LCK WNK1 SUOX GCLC CDIPT GLUD1 PRKCH CHST2 TALDO1 PRG4 | 6.06e-05 | 1292 | 165 | 23 | CID000001117 |
| Drug | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 6.09e-05 | 184 | 165 | 8 | ctd:C576882 | |
| Drug | AC1O4QJG | 7.45e-05 | 60 | 165 | 5 | CID006398504 | |
| Drug | 6-methylpurine-2'-deoxyriboside | 8.06e-05 | 61 | 165 | 5 | CID000097184 | |
| Drug | 17beta-estradiol glucuronide | 8.16e-05 | 32 | 165 | 4 | CID000066424 | |
| Drug | coprostanol | 8.16e-05 | 32 | 165 | 4 | CID000003240 | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 193 | 165 | 8 | 7176_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 4134_DN | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 8.82e-05 | 194 | 165 | 8 | 7125_DN | |
| Drug | magnesium | ACAA1 DNAH10 MYO5A SPR PDHB MMP21 SRR LCK ARHGAP35 NDUFAB1 WNK1 DNAH1 NLRP14 ATP2C1 NF1 FDPS FLAD1 PRKCH ALDH3A2 ATP1B3 TALDO1 TOP3A MVK | 8.86e-05 | 1325 | 165 | 23 | CID000000888 |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.14e-05 | 195 | 165 | 8 | 3834_DN | |
| Drug | glutarate | 9.50e-05 | 101 | 165 | 6 | CID000000743 | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 6867_UP | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 4832_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 9.81e-05 | 197 | 165 | 8 | 5519_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3754_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3417_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 3680_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 165 | 8 | 2256_DN | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 1.02e-04 | 198 | 165 | 8 | 1135_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A | 1.05e-04 | 199 | 165 | 8 | 4_DN | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 1270_UP | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 165 | 8 | 6002_DN | |
| Drug | Spironolactone | 1.06e-04 | 103 | 165 | 6 | ctd:D013148 | |
| Drug | thioinosine | 1.17e-04 | 35 | 165 | 4 | CID000676166 | |
| Drug | acetate | ACAA1 HAGHL PDHB ACO1 MMP21 NDUFAB1 DNAH1 ATP2C1 GLUD1 PRKCH HADHB SLC5A8 ALDH3A2 TALDO1 | 1.24e-04 | 599 | 165 | 14 | CID000000175 |
| Drug | Pravastatin | 1.26e-04 | 67 | 165 | 5 | ctd:D017035 | |
| Drug | pentachloronitrobenzene | 1.28e-04 | 14 | 165 | 3 | CID000006720 | |
| Drug | tetramethylrosamine | 1.28e-04 | 14 | 165 | 3 | CID000443313 | |
| Drug | AC1L1G4Q | 1.31e-04 | 36 | 165 | 4 | CID000003524 | |
| Drug | CPDS | 1.36e-04 | 68 | 165 | 5 | CID000085040 | |
| Drug | oleoyl-lysophosphatidic acid | MBTPS1 HIF1A LCK ARHGAP35 NDUFAB1 SH3GLB1 EGR1 MTOR PAK1 PRKCH TALDO1 | 1.38e-04 | 391 | 165 | 11 | CID000003987 |
| Drug | sterol | 1.41e-04 | 265 | 165 | 9 | CID000001107 | |
| Drug | sodium glycocholate | 1.45e-04 | 69 | 165 | 5 | CID000000755 | |
| Drug | benzbromarone | 1.46e-04 | 37 | 165 | 4 | CID000002333 | |
| Drug | 5-propyl-2-thiouracil | 1.56e-04 | 3 | 165 | 2 | CID003002043 | |
| Drug | harmol glucuronide | 1.56e-04 | 3 | 165 | 2 | CID005488285 | |
| Drug | levulinic acid | 1.56e-04 | 3 | 165 | 2 | CID000011578 | |
| Drug | PAK-104P | 1.60e-04 | 15 | 165 | 3 | CID000131368 | |
| Drug | dichloromethanediamine | ABCC3 SP1 ABCC4 HIF1A CYP27A1 EGR1 GCLC MTOR PAK1 PRKCH PRKDC TOP3A RAD23B | 1.60e-04 | 539 | 165 | 13 | CID005311048 |
| Drug | Metformin | ABCC3 SP1 MYH6 HIF1A SLCO2B1 PNPLA6 EGR1 GCLC MTOR TALDO1 ABCG5 | 1.69e-04 | 400 | 165 | 11 | ctd:D008687 |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 6.66e-05 | 15 | 159 | 3 | DOID:0050908 (implicated_via_orthology) | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 8.17e-05 | 16 | 159 | 3 | DOID:0060250 (implicated_via_orthology) | |
| Disease | haptoglobin measurement | 1.90e-04 | 21 | 159 | 3 | EFO_0004640 | |
| Disease | porokeratosis (is_implicated_in) | 2.85e-04 | 5 | 159 | 2 | DOID:3805 (is_implicated_in) | |
| Disease | Hereditary Autosomal Dominant Spastic Paraplegia | 2.85e-04 | 5 | 159 | 2 | C0751602 | |
| Disease | HMSN Type V | 2.85e-04 | 5 | 159 | 2 | C4721916 | |
| Disease | Drug habituation | 4.06e-04 | 115 | 159 | 5 | C0013170 | |
| Disease | Drug abuse | 4.06e-04 | 115 | 159 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.06e-04 | 115 | 159 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.06e-04 | 115 | 159 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.06e-04 | 115 | 159 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.06e-04 | 115 | 159 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.06e-04 | 115 | 159 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.06e-04 | 115 | 159 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.06e-04 | 115 | 159 | 5 | C0029231 | |
| Disease | Substance abuse problem | 4.23e-04 | 116 | 159 | 5 | C0740858 | |
| Disease | Porokeratosis, Disseminated Superficial Actinic | 4.27e-04 | 6 | 159 | 2 | C0265970 | |
| Disease | cytotoxicity measurement, response to clozapine | 5.06e-04 | 29 | 159 | 3 | EFO_0006952, GO_0097338 | |
| Disease | Alzheimer's disease (is_marker_for) | 5.08e-04 | 257 | 159 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Prostatic Neoplasms | MBTPS1 ABCC4 HIF1A PAK6 CREBBP EGR1 BRPF1 ZFHX3 PRKDC ABCG5 RAD23B | 5.37e-04 | 616 | 159 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | MBTPS1 ABCC4 HIF1A PAK6 CREBBP EGR1 BRPF1 ZFHX3 PRKDC ABCG5 RAD23B | 5.37e-04 | 616 | 159 | 11 | C0376358 |
| Disease | hereditary lymphedema (is_implicated_in) | 5.95e-04 | 7 | 159 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | migraine disorder, glucose measurement | 6.18e-04 | 31 | 159 | 3 | EFO_0004468, MONDO_0005277 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 7.44e-04 | 33 | 159 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 9.06e-04 | 206 | 159 | 6 | C0152013 | |
| Disease | apolipoprotein B measurement | SP1 DNAH10 PDHB DHX38 IQGAP1 CEACAM19 NF1 SLC22A5 ZFHX3 HYDIN ABCG5 | 9.78e-04 | 663 | 159 | 11 | EFO_0004615 |
| Disease | response to corticosteroid, age at assessment | 1.26e-03 | 10 | 159 | 2 | EFO_0008007, GO_0031960 | |
| Disease | Complications of Diabetes Mellitus | 1.54e-03 | 11 | 159 | 2 | C0342257 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.65e-03 | 157 | 159 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Liver carcinoma | 1.78e-03 | 507 | 159 | 9 | C2239176 | |
| Disease | Adenocarcinoma of large intestine | 1.84e-03 | 96 | 159 | 4 | C1319315 | |
| Disease | urate measurement, bone density | 2.01e-03 | 619 | 159 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | ximenoylcarnitine (C26:1) measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800543 | |
| Disease | cerotoylcarnitine (C26) measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0800542 | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.29e-03 | 102 | 159 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 2.36e-03 | 49 | 159 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Malformations of Cortical Development | 2.52e-03 | 14 | 159 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 2.52e-03 | 14 | 159 | 2 | C0431380 | |
| Disease | response to varenicline, Nausea | 2.89e-03 | 15 | 159 | 2 | EFO_0600052, HP_0002018 | |
| Disease | hepatoblastoma (is_marker_for) | 2.89e-03 | 15 | 159 | 2 | DOID:687 (is_marker_for) | |
| Disease | glycerate measurement | 2.89e-03 | 15 | 159 | 2 | EFO_0021029 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.89e-03 | 15 | 159 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.89e-03 | 15 | 159 | 2 | DOID:655 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 2.94e-03 | 260 | 159 | 6 | EFO_0008317 | |
| Disease | red blood cell density measurement | THSD4 SP1 DNAH10 ACO1 PIEZO1 MCM4 WNK1 ITIH3 SALL1 ASB16 GLUD1 PSD4 | 3.01e-03 | 880 | 159 | 12 | EFO_0007978 |
| Disease | Intellectual Disability | 3.03e-03 | 447 | 159 | 8 | C3714756 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 3.08e-03 | 352 | 159 | 7 | EFO_0007014 | |
| Disease | Peripheral Nervous System Diseases | 3.11e-03 | 54 | 159 | 3 | C4721453 | |
| Disease | Metastatic melanoma | 3.11e-03 | 54 | 159 | 3 | C0278883 | |
| Disease | amyloid-beta measurement | 3.23e-03 | 355 | 159 | 7 | EFO_0005194 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.72e-03 | 17 | 159 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 3.72e-03 | 17 | 159 | 2 | EFO_0010390 | |
| Disease | Hypertensive disease | 3.75e-03 | 190 | 159 | 5 | C0020538 | |
| Disease | Polydactyly | 3.75e-03 | 117 | 159 | 4 | C0152427 | |
| Disease | Atherosclerosis | 4.00e-03 | 59 | 159 | 3 | C0004153 | |
| Disease | Atherogenesis | 4.00e-03 | 59 | 159 | 3 | C1563937 | |
| Disease | atrial fibrillation | 4.10e-03 | 371 | 159 | 7 | EFO_0000275 | |
| Disease | C-X-C motif chemokine 16 measurement | 4.17e-03 | 18 | 159 | 2 | EFO_0010911 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 4.65e-03 | 19 | 159 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.16e-03 | 128 | 159 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.16e-03 | 128 | 159 | 4 | C0007134 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.25e-03 | 65 | 159 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | monocyte count | CRYBG2 CDC42BPA PIEZO1 MEI1 WNK1 NCOR2 NF1 GCLC FGD4 SLC22A5 PRKDC CHST2 ATP1B3 KLRC1 MVK | 5.26e-03 | 1320 | 159 | 15 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNLVGMGVIPLEYLP | 806 | P21399 | |
| LAIIEYMPLLAGQLG | 421 | P30153 | |
| LVNQYLPGEGIMPHE | 101 | Q3KRA9 | |
| YPTMLDIAGIPLPQN | 361 | Q6UWY0 | |
| PEVLQGLYQAPLSMD | 411 | Q17RC7 | |
| GMLEVPLCQILPYAD | 541 | A0FGR9 | |
| PEIVNYEPLGLEADM | 186 | P53355 | |
| TPLEVQMAQPNYGLE | 1061 | Q8NHU2 | |
| GQYIMSLPLNLEPFV | 631 | P83436 | |
| PIEAIIYLDQGSPEM | 171 | Q96CG8 | |
| NGEVPQLVLYMGILL | 256 | P0DMS8 | |
| NETLRPGYEMISNPL | 181 | Q8N2C3 | |
| PGYEMISNPLAQEIG | 186 | Q8N2C3 | |
| RQYSDMPPLTLEGIQ | 66 | O14561 | |
| AALLDYGAQPVRPEM | 341 | Q96NS5 | |
| GIPDYFDIVKNPMDL | 1121 | Q92793 | |
| MLDEAYIQPQPLGVV | 91 | P51648 | |
| ANMPEYNAPALLELV | 656 | Q8IY63 | |
| AYVPADPAQLAAQML | 166 | O75952 | |
| PLPYPNLDTFLDDMN | 231 | P23109 | |
| PDEGPNAQIMYQIVE | 1026 | Q9NYQ6 | |
| GVDLQGYQLDMQILP | 21 | Q32M45 | |
| MPDENIFLFVPNLIG | 1 | O14735 | |
| MYVSQDPKDQLLLGP | 341 | P55084 | |
| NPALDDPTPDYMNLL | 26 | Q9Y284 | |
| SIMGQLLVIYFPPLQ | 851 | P98194 | |
| MLELPLVIGTIPYNG | 306 | Q8NCT1 | |
| NAMDEIGLPKIFYPE | 121 | P46940 | |
| MDNQGVIYSDLNLPP | 1 | P26715 | |
| NNPDRAVEYLLMGIP | 216 | P54727 | |
| QMYQSLAELGTLPPE | 151 | Q6PII5 | |
| DGQVSEMGPYPALLQ | 826 | O15438 | |
| LLMYVGPASPQADGQ | 256 | A6NDH6 | |
| PLEGTQHLQDVPYVM | 1001 | Q14126 | |
| SMLYIEDPLQPGNDV | 356 | Q8NDF8 | |
| PLYMQRLGEINVIGE | 191 | P33991 | |
| QLAVIPPMLYDADQQ | 391 | Q9Y618 | |
| PVVVLENELMYGVPF | 196 | P11177 | |
| LLMDGGYINNLPADI | 1131 | Q8IY17 | |
| PLGEYQELLPIFMQL | 336 | Q9Y4B6 | |
| ITPMLNPIIYGLRNN | 281 | Q8NGE5 | |
| MPVDGYISGLLNDIQ | 76 | Q9NQU5 | |
| AEVPLADPGMYQLDI | 251 | Q6DN14 | |
| LPQDPSFQMPLDLYA | 251 | Q08380 | |
| PLYGTLNNPADQMDV | 341 | Q14703 | |
| IMALIEQYAAPLPPA | 391 | P14324 | |
| EEVPLYNDVMLPSPN | 426 | Q16665 | |
| PINVPGMVLYSDDEN | 991 | Q5CZC0 | |
| MIPDYLFPQQQGDLG | 251 | P18146 | |
| LEVPVMLTEQYPQGL | 51 | Q96AB3 | |
| MQPNYIPQEPAFELD | 301 | Q8N119 | |
| EGYVPNLRNSPLEIM | 366 | Q8WWZ8 | |
| ILLANLYVAVPPMLN | 276 | Q96RD2 | |
| QATIPLLGYVVDEMP | 686 | Q96M96 | |
| FPGLIPILNSYLENM | 531 | P48506 | |
| MNAIGLIITALPEPY | 1146 | Q9ULK4 | |
| PEIVNYEPLGLEADM | 186 | O43293 | |
| LVFPPGMEELQAQLE | 251 | P16050 | |
| YPGMTNPEVIQNLER | 441 | P06239 | |
| IMIGLQYQAEIPPYL | 176 | Q7Z3K6 | |
| EIQPQMLVELAPPYF | 661 | Q8TE96 | |
| PRLGQMIVDYENPLK | 176 | Q9Y2A7 | |
| LMGYNDQVQRPIPLT | 566 | O95140 | |
| YVPPMIEGNLATPLN | 1636 | Q96RW7 | |
| PPVQYGELQALLEAM | 451 | Q5TIA1 | |
| MLPVYQEVKPNPLQD | 1 | O15439 | |
| EMIEGEPPYLNENPL | 456 | Q13153 | |
| PLNPQGMEELEVEFL | 171 | Q3MJ16 | |
| YLLGPVLHLPQMGDQ | 41 | Q9UBC7 | |
| LNMPALETYGAQPPI | 2296 | Q9P2D7 | |
| PVIQTPDMQRGLDYF | 2261 | Q8NCM8 | |
| IQEMDGVEPVLYPLL | 3326 | Q8NCM8 | |
| AEGLMEQNYPTPDPL | 766 | Q05DH4 | |
| PASMELYPGQAIDVI | 991 | Q4G0P3 | |
| GVPPDMLQLLLDFSY | 81 | Q9UJP4 | |
| LVPNVPYFDLPAGLM | 641 | Q8IWX8 | |
| PEIVNYEPLGLEADM | 196 | Q9UIK4 | |
| NIMVIPDLYLNAGGV | 421 | P00367 | |
| PPAQSMVQALELLYA | 451 | Q9H5Z1 | |
| PVVLGEQVQLPYQDM | 461 | O43909 | |
| APLLEQVMRQEGKYP | 111 | Q02318 | |
| MYATLPAIEEDQLGP | 796 | Q8N1P7 | |
| LVFKIAPMLNPDGVY | 261 | Q5VU57 | |
| LAIPAAQLVVLPYQM | 376 | Q92771 | |
| MAYLDQTLPRAPGQA | 831 | Q92771 | |
| PYTGMLNAVNLFPVL | 431 | Q9H222 | |
| DYLQSPLQPLMDNLE | 306 | O14744 | |
| GDNNIYEVMPSPVLL | 236 | Q7Z692 | |
| INQLPLFLGEPAMEF | 341 | Q5T6L9 | |
| LNMLFAPPGALYAEV | 381 | Q9BYK8 | |
| LPQGSLVPYMPNAVE | 346 | Q8NFF5 | |
| MPRVDEYGTQQPIAL | 2526 | Q8IVF4 | |
| GYNPMIPAENIENVV | 2976 | Q8IVF4 | |
| GSVLLFMQLVPPDLY | 411 | O76082 | |
| IQMNPYPVPEHLDNI | 506 | Q9NSC2 | |
| YVTPVLLQMGLPDQL | 141 | Q9Y2W3 | |
| IAMLEPLTVDLNPQY | 451 | Q96EK5 | |
| IHLQPQLIPPNMEEY | 521 | Q9BTE3 | |
| DVMPALLYQTPAGDL | 741 | Q9Y6K5 | |
| VNMGNLPLDEFYPAV | 936 | P42345 | |
| QLLPQGPLVQYLTME | 716 | O43196 | |
| GTLQYMAPEIIDQGP | 811 | Q6ZN16 | |
| QYMRNGELPAEQAIP | 1476 | Q93008 | |
| MPIGGDVPALQLQYD | 2586 | P46939 | |
| IMGIGPAYAIPVALQ | 316 | P09110 | |
| IPSDAYDVLLLPMQA | 1081 | O60522 | |
| SLPPVNMYDLFEALQ | 271 | Q96BN2 | |
| DGIVQIQGMEYQPIP | 141 | Q9H9A7 | |
| IQGMEYQPIPILHSD | 146 | Q9H9A7 | |
| EVANPLLTGVEMEYP | 466 | Q06033 | |
| LGIAYPIIDGIPNMI | 81 | Q96I23 | |
| PQPMEILNLYLGDSL | 11 | Q8NDX1 | |
| LVQPKEDMEAVPGYL | 266 | O43147 | |
| INNPELLGQYMIDAG | 91 | Q9Y371 | |
| VSAPDQLMPYLVLDI | 316 | Q8N695 | |
| MIEPFGNQYIVARPV | 1 | P40879 | |
| LMPNLYPPETIADGV | 226 | Q9GZT4 | |
| LTGLPGVMPNIQYQV | 161 | P08047 | |
| PELLDMLLVTNNPYD | 296 | P13533 | |
| DMILYPLIGIPQTIN | 21 | Q6NSI8 | |
| PDYISPEILQAMEDG | 241 | Q5VT25 | |
| SELPDPLVPYNMQID | 1326 | Q9NRY4 | |
| MPGFDIIPYNDLPAL | 201 | P04181 | |
| DMDYLPRVPNQGIII | 1121 | Q92954 | |
| LIINIMSAEDFPLPY | 146 | O43556 | |
| MTLLPEVGNPYSQQL | 956 | O94855 | |
| PELYLLPVMDHLGNV | 131 | Q5VX52 | |
| GVSPIPQEIFEYLMD | 236 | P55201 | |
| EDIPNVAVYPHNGMI | 196 | P54709 | |
| EPGEQPIYMNFSEPL | 181 | A8K4G0 | |
| QPMAVLGYERVNSPE | 501 | Q9Y4C5 | |
| GQLPQHEYLKEMEPL | 2161 | Q6P2Q9 | |
| PNMLGIIPYAGIDLA | 341 | Q6KCM7 | |
| PILTEEMYGDIQPAA | 1581 | Q8N2C7 | |
| GDYQLPVVVLMLNLP | 461 | Q99797 | |
| YLPVMPDGSVLLVDN | 266 | Q8WVR3 | |
| LYVDINQMPEGGISL | 251 | O94956 | |
| EMGEAPAPEQYLVLE | 281 | Q03426 | |
| NEPEFLGIVTEYMPN | 86 | O43353 | |
| DNKQMGLQPYPEILV | 511 | O43353 | |
| VRVLNYAPGPLDTDM | 191 | P35270 | |
| YAPGPLDTDMQQLAR | 196 | P35270 | |
| PDLPGIANDLMYIAD | 251 | Q6VEQ5 | |
| PYAQLQAMPAAGGVL | 566 | O14964 | |
| VGLELSPALYPMLFN | 921 | P21359 | |
| FNPRIGMDALQIYPI | 831 | Q92620 | |
| EVVAPFMANIPLLLY | 166 | P07602 | |
| FMANIPLLLYPQDGP | 171 | P07602 | |
| LAQQEDIYPAMPEPI | 641 | Q13472 | |
| LLGIVMANDLPPYDP | 2276 | P78527 | |
| VMLENYQNLLALGPP | 71 | Q16587 | |
| PSLILAAAQMPAYQE | 46 | P37837 | |
| VLLAYEMNGQPLPRD | 346 | P51687 | |
| YGAMIPTQLPQELDF | 41 | Q5VWN6 | |
| SSEEPLGVLVNPNMY | 371 | Q15650 | |
| YQMPLAQALLPPAGI | 266 | Q92508 | |
| ALSLVGEPIMYPEIN | 481 | Q9NV66 | |
| QPYVESNLLVPMGGV | 996 | Q9H4A3 | |
| EILDVYMIHQQPNPG | 506 | Q6ZMP0 | |
| NISYEMLFEPEPNGV | 1001 | Q9HAU0 | |
| LSMGQYLQAEPIVLG | 2156 | P31629 | |
| LGLDMPNCTYILDPE | 81 | Q05996 | |
| YQLLQGDGTALMPPV | 436 | Q9H091 | |
| MIPQDEYPEINFVGL | 141 | Q15637 | |
| MLEPQENGVIDLPDY | 1 | Q9BVW5 | |
| AGYIEDLVLMLPQNI | 776 | Q8TEY7 | |
| YNGVPLDGRPMNIQL | 166 | Q86V81 | |
| NEGLLYPNPAAQMLV | 796 | Q15386 | |
| LPDLVPQLGTLYQLM | 541 | Q15061 | |
| LPTMEYAVDPAQLQA | 3276 | Q15911 | |
| TGPQLPESLEDVAMY | 211 | O14978 | |
| GTPDYIAPEILQEML | 516 | P24723 | |
| IAPEILQEMLYGPAV | 521 | P24723 | |
| EGPIEEIMYQPSSLL | 241 | Q86W24 | |
| AVNLIPGLPAYILFM | 1501 | Q9Y4I1 |